WitrynaL.V.E. is a scientific founder of ImmunoChem Therapeutics, LLC, a Northwestern spin-out formed to commercialize MW189. Northwestern University and the University of Kentucky might benefit if MW189 is successful commercially. J.T.G. is supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of … WitrynaRibi ImmunoChem Research, Inc. is a biopharmaceutical firm founded in 1981 that develops novel agents that modulate the human immune response to prevent or treat …
Immunochem Innovation in health
WitrynaDr. Elias A. Zerhouni M.D. has been the chairman and co-founder of ModeX therapeutics Inc., a start-up biotechnology company focused on multi specific-immune therapies for cancer and viral diseases, since November 2024. A physician scientist in Imaging and Biomedical Engineering, he served as President of global R&D and … WitrynaSwitzerland, US. United States. Worldwide. * In collaboration with MEI Pharma. † This combination is being studied in the third cohort of NCT03336333. CDAC chimeric … candy expert
Board of Directors — Innovation Pharmaceuticals Inc.
WitrynaOur Company Immunomic Therapeutics, Inc. (ITI) is a privately held, clinical stage biotechnology company pioneering the development of vaccines through its … WitrynaPartnerships. At CRISPR Therapeutics, partnerships form a core component of our strategy, allowing us to access capabilities and resources to support our therapeutic programs. We are interested in partnering with biopharma companies, academic centers, universities and other relevant organizations. For inquiries, please contact us at … WitrynaIMMUNOCHEM THERAPEUTICS LLC. Company Information. Address. 105 AUBURN ST. AUBURNDALE, MA 02466-2524. United States. Information. UEI: … fish tuckners